PRVA Stock Forecast & Price Target

Privia Health Group Inc. has demonstrated a positive trajectory by successfully adding 125 providers in the fourth quarter of 2025, which indicates strong growth potential as the company continues to expand its operations across various states. The company reported a sequential increase of approximately 9% in practice collections per provider, totaling around $80 million, thanks in part to improved performance in its capitated Medicare Advantage portfolio and enhanced operational efficiencies. Additionally, ongoing growth in new provider additions and patient visit volumes positions Privia favorably for sustained revenue generation, particularly with expectations for increased contributions from the newly tapped Arizona market through 2025.

Privia Health Group Inc. faces a negative outlook primarily due to anticipated declines in Medicaid enrollment, with expectations of an 8%-10% decrease impacting revenue and EBITDA guidance. The company is also susceptible to hesitancy among physicians regarding the transition to value-based care (VBC), driven by evolving CMS policy and concerns over financial unpredictability. Furthermore, there is a notable expectation of a sequential decline in EBITDA following an unusually strong Q3 performance, undermining the stability typically observed in previous years.